CellaVision AB (CEVI) - Total Liabilities

Latest as of December 2025: Skr207.31 Million SEK ≈ $22.31 Million USD

Based on the latest financial reports, CellaVision AB (CEVI) has total liabilities worth Skr207.31 Million SEK (≈ $22.31 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore CellaVision AB cash flow conversion to assess how effectively this company generates cash.

CellaVision AB - Total Liabilities Trend (2000–2025)

This chart illustrates how CellaVision AB's total liabilities have evolved over time, based on quarterly financial data. Check financial resilience of CellaVision AB to evaluate the company's liquid asset resilience ratio.

CellaVision AB Competitors by Total Liabilities

The table below lists competitors of CellaVision AB ranked by their total liabilities.

Company	Country	Total Liabilities
Xinjiang Youhao Group Co Ltd SHG:600778	China	CN¥3.15 Billion
Yunnan Bowin Technology Industry Co Ltd SHG:600883	China	CN¥60.19 Million
United Malacca Bhd KLSE:2593	Malaysia	RM319.41 Million
Medios AG XETRA:ILM1	Germany	€388.82 Million
K&F Growth Acquisition Corp. II Class A Ordinary shares NASDAQ:KFII	USA	$10.15 Million
Know Labs Inc. NYSE MKT:KNW	USA	$5.28 Million
Canada Nickel Company Inc V:CNC	Canada	CA$60.31 Million
Maritima De In SN:MARINSA	Chile	CL$13.41 Billion

Liability Composition Analysis (2000–2025)

This chart breaks down CellaVision AB's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see CellaVision AB (CEVI) market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	3.98	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.23	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.19	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how CellaVision AB's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for CellaVision AB (2000–2025)

The table below shows the annual total liabilities of CellaVision AB from 2000 to 2025.

Year	Total Liabilities	Change
2025-12-31	Skr207.31 Million ≈ $22.31 Million	+5.68%
2024-12-31	Skr196.16 Million ≈ $21.11 Million	-7.61%
2023-12-31	Skr212.32 Million ≈ $22.85 Million	-15.11%
2022-12-31	Skr250.12 Million ≈ $26.92 Million	-11.28%
2021-12-31	Skr281.93 Million ≈ $30.34 Million	+18.26%
2020-12-31	Skr238.41 Million ≈ $25.66 Million	-18.73%
2019-12-31	Skr293.34 Million ≈ $31.57 Million	+255.96%
2018-12-31	Skr82.41 Million ≈ $8.87 Million	+37.93%
2017-12-31	Skr59.75 Million ≈ $6.43 Million	+18.85%
2016-12-31	Skr50.27 Million ≈ $5.41 Million	+36.20%
2015-12-31	Skr36.91 Million ≈ $3.97 Million	-27.56%
2014-12-31	Skr50.95 Million ≈ $5.48 Million	-9.11%
2013-12-31	Skr56.06 Million ≈ $6.03 Million	+4.50%
2012-12-31	Skr53.64 Million ≈ $5.77 Million	+1.87%
2011-12-31	Skr52.66 Million ≈ $5.67 Million	+7.30%
2010-12-31	Skr49.08 Million ≈ $5.28 Million	+27.30%
2009-12-31	Skr38.55 Million ≈ $4.15 Million	-23.64%
2008-12-31	Skr50.49 Million ≈ $5.43 Million	+109.95%
2007-12-31	Skr24.05 Million ≈ $2.59 Million	+1.92%
2006-12-31	Skr23.60 Million ≈ $2.54 Million	+19.90%
2005-12-31	Skr19.68 Million ≈ $2.12 Million	-27.03%
2004-12-31	Skr26.97 Million ≈ $2.90 Million	+20.07%
2003-12-31	Skr22.46 Million ≈ $2.42 Million	-10.24%
2002-12-31	Skr25.02 Million ≈ $2.69 Million	-23.58%
2001-12-31	Skr32.74 Million ≈ $3.52 Million	+79.77%
2000-12-31	Skr18.21 Million ≈ $1.96 Million	--

About CellaVision AB

ST:CEVI Sweden Medical Devices

Market Cap

$311.10 Million

Skr2.89 Billion SEK

Market Cap Rank

#14799 Global

#231 in Sweden

Share Price

Skr121.20

Change (1 day)

-1.14%

52-Week Range

Skr120.20 - Skr200.00

All Time High

Skr478.48